Sacituzumab govitecan in HER2-negative breast cancer: redefining treatment paradigms
Year: 2025
Type: review
Source: Journal of drug targeting
Authors: Avinash Khadela, Kashvy R. Morakhia, Nishra H. Shah, Vibha G. Kanjani, Vraj B. Shah, Hetvi B. Bharadia, Rushabh Kothari, Manthan Merja
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4411701403